The present invention provides a method for preparing an ultra high molecular weight polyethylene (UHMWPE) composite material including the following steps: providing a substrate material having medical grade ultra high molecular weight polyethylene powders, drying the substrate material to obtain fully dried UHMWPE powders, and pressing the fully dried UHMWPE powders to form a UHMWPE board; immersing the UHMWPE board into a graphene oxide solution and performing an ultrasonic induction by an ultrasonic processor such that the graphene oxide solution infiltrates into the UHMWPE substrate to obtain an ultra high molecular weight polyethylene composite material with excellent biocompatibility and tribological properties. The graphene oxide can be adsorbed and evenly spread on the surface of UHMWPE substrate by ultrasonic induction to form a lubricating film which can effectively reduce wear.

A composite article can comprise a composite body including an organic polymer and ceramic particles comprising hexagonal boron nitride (hBN) particles distributed throughout the organic polymer, wherein an amount of the hBN particles ranges from 40 vol % to 90 vol % based on a total volume of the body; and the body comprises an in plane thermal conductivity of at least 15 W/mK. The hBN particles within the composite body can have a March-Dollase Orientation parameter η of at least 50%.

The present invention relates to a method for producing a molded body (10), comprising the following steps: a) providing a molding tool (40) which has at least one receptacle (12) in which at least one material (30) which comprises at least one shape-memory material (31) is introduced, wherein the shape-memory material (31) is present in a first state (111), wherein the material (30) at least partially fills the receptacle (12) of the molding tool (40) in such a manner that said material adjoins at least one surface of the receptacle (12); b) creating a molded body (10) in the receptacle (12) of the molding tool (40) from the material (30), wherein the shape-memory material (31) is present in a second state (112), wherein a form (11) is embossed into the molded body (10) during the second state (112); c) transferring the shape-memory material (31) to a third state (113), wherein the molded body (10) can be deformed during the third state (113) in such a manner that the molded body (10) is demolded from the receptacle (12) of the molding tool (40); and d) at least partially restoring the form (11) of the molded body (10) by transferring the shape-memory material (31) to a fourth state (114), wherein the molded body (10) at least partially resumes the form (11) according to step b) during the fourth state (114).

Systems and methods for forming pellets from mixed plastic materials are disclosed. An example method may include a method for forming pellets from mixed plastic materials without needing to screen or filter the mixed plastic materials. The method may include disposing a mixed plastic material into an extrusion apparatus, advancing the mixed plastic material through a die to form strands, and cutting the strands into a plurality of pellets.

A mechanically and piezoelectrically anisotropic polymer thin film may be formed by gel casting a solution that includes a crystallizable polymer and a liquid solvent. The solvent may be configured to interact with the polymer to facilitate chain alignment and, in some examples, create a higher crystalline content within the cast thin film. The thin film may also include up to approximately 90 wt. % of an additive and may be characterized by a bimodal molecular weight distribution of a crystallizable polymer where the molecular weight of the additive may be less than the molecular weight of the crystallizable polymer. In some examples, the polymer(s) and the additive(s) may be independently selected from vinylidene fluoride, trifluoroethylene, chlorotrifluoroethylene, hexafluoropropene, vinyl fluoride, etc. The anisotropic polymer thin film may be characterized by an electromechanical coupling factor (k.sub.31) of at least 0.1.

A method of infusing, infiltrating or impregnating a three dimensional printed, free-form fabricated or additive manufactured object having pores or voids in or between particles or sheets of material from which the object is manufactured may include infusing the object with a thermoplastic material. The thermoplastic material may be a linear or branched semi-crystalline aliphatic polyester with a melting point of between 40° C. and 65° C. which may have a solidification/crystalisation point between 20° C. and 40° C., and which may be introduced under controlled conditions of temperature and pressure. The thermoplastic material may be caused to penetrate the object by immersing the object in the thermoplastic material and controlling the frequency and amplitude of pressure oscillation to ensure sufficient infusion into the object to penetrate the pores or voids by at least 10% and bond particles or sheets of material from which the object is manufactured.

A method for removing powder from a component or part produced by a powder bed additive manufacturing system is provided. The method includes providing a part, the part having at least one internal cavity with at least one external opening, the at least one cavity being at least partly filled with powder grains, the powder grains being connected to each other and to the walls of the cavity by mechanical, frictional, electrical, physical, or chemical forces. The method further includes adding medium in liquid phase to the at least one cavity of the part, the liquid having the property that it expands in phase transition from liquid to solid phase; transforming added medium to solid phase to loosen and break up at least a fraction of the powder grains connections from each other; and removing powder from the at least one internal cavity.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

A crystallized bioabsorbable polymer scaffold comprises a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold is cold-bendable.